Take Your Biotech Marching Orders from This Stock

22Jun1:32 pmEST

Karma is on Hold for Pharma

Against the backdrop of a pill-popping population and pill-peddling physicians more than toeing the line over the Hippocratic Oath , i t felt so right and righteous to see the pharma stocks mostly get clobbered in recent quarters. On a nightly basis for Members since late-2015, we were consistently bearish the likes of MNK NBIX HZNP VRX,...

22Jun10:40 amEST

The Most Beautiful Solar Wall You Have Ever Seen

For the politically-charged dogmatic types, it may very well prove to be the ultimate plot twist if solar stocks performed terribly in the Obama years only to then bottom in the first few months of a Trump presidency and stage a new bull run. First things first, though, and with Trump floating the idea of a "Solar Wall" on the U.S./Mexico...

21Jun3:46 pmEST

Stock Market Recap 06/21/17 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets If you enjoy my videos and blog posts, then please...

21Jun3:44 pmEST

Come on, Kryptonite!

At the risk of a "Mush" situation, it looks as though we have some form of speculative fervor taking place in the biotech arena, with healthcare names on the outskirts of town also getting a boost. At this point, some are rather extended while others are not, which of course means we need to hone in on the ones setting up at present. To...

21Jun1:17 pmEST

Crude, Where's My Bottom?

Once again, the small cap weakness coupled with persistent selling in the energy sector at-large seems to be slightly outweighing biotech and select tech strength today. As a result, I am not forcing in new longs for what is an increasingly divergent market. As an aside, it is interesting to see the solar outperformance, however, with RUN VSLR...

21Jun10:45 amEST

Tweets Versus Eats

The main issue with the early strength in Twitter's stock this morning is that it is so widely-watched and sees such knee-jerk cheerleading that it is usually best to see if the move can actually hold beyond a few hours. TWTR is still potentially in the later stages of a major bottom after enduring a severe downtrend for years after an initial,...

20Jun3:45 pmEST

Stock Market Recap 06/20/17 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets If you enjoy my videos and blog posts, then please...

20Jun3:44 pmEST

Not Enough Juice for the Euphoria Gambit

It appears as though some glaring weakness in tech and small caps today, alongside various other selling in the likes of CMG and DIS, is overpowering the rotation into biotech to spark some type of frenzy buying into July 4th. Intel, for example, below on the daily chart, is breaching $35 prior support and is now at risk of severely weighing...

20Jun1:32 pmEST

Less Flash, More Substance

On the back of yesterday's rally, of which we have seen similar types of sessions in recent weeks, we also have seen similar types of givebacks the following day. Indeed, some more substance to follow-up the rally and bullish setups would be favored for long-minded traders. Instead, despite some good action in biotech, again, the market is...

20Jun10:38 amEST

Take Your Biotech Marching Orders from This Stock

Barring some stock-specific news anytime soon, I suspect the issue of whether the biotechnology sector rally not only continues to hold but also broadens out can be seen in the likes of Amgen and a few other IBB plays. Specifically, the AMGN monthly chart, below, indicates the stock has essentially been sideways for roughly two and a half...